Arizona Bioscience News: Tempe I.D.E.A project to start construction; UA licenses skin cancer drugs; Banner Health plans Chandler hospital

June 14, 2018

By Matt Ellsworth

Flinn Foundation employment opportunity - VP bioscience researchUA licenses drugs to help prevent skin cancer / Arizona Daily Star

The University of Arizona is moving to commercialize two faculty-invented drug compounds that could help protect people from sun damage and skin cancer by boosting the skin’s natural pigment.

Banner Health to build $150M hospital in Chandler / Phoenix Business Journal

Banner Health plans to build a $150 million, 240,000-square-foot hospital in Chandler—its first in the city—that is scheduled to open in fall 2020 with 120 beds and room for expansion.

Arizona study links HPV, cervical cancer to vaginal microbes / KJZZ

A new study of Arizona women by the University of Arizona College of Medicine-Phoenix, Maricopa Integrated Health Systems, Dignity Health St. Joseph’s Hospital and Medical Center, UA Cancer Center and U.S. Oncology could help explain why some women with HPV develop cervical cancers while others do not.

Construction underway for major technology campus in Tempe / KTAR

Construction has started in Tempe on a major tech project called I.D.E.A., or Innovation, Discovery, Education and Arts, which will stretch 18 acres along Tempe Town Lake and include more than 1 million square feet for biotech and technology companies with the first phase set to open in 2020.

Two major expansions in the works for UA Tech Parks / Inside Tucson Business

UA Tech Park at The Bridges is a future technology hub, modeled off of innovative districts from other universities, with plans for more than 2 million square feet of lab and office space as well as a hotel and conference center.